Get the Stockscreener App
0.8334
1.61%
-0.0136
After Hours:
.83
-0.0034
-0.41%
Shattuck Labs Inc stock is traded at $0.8334, with a volume of 94,167.
It is down -1.61% in the last 24 hours and down -18.29% over the past month.
Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.
See More
Previous Close:
$0.847
Open:
$0.8699
24h Volume:
94,167
Relative Volume:
0.58
Market Cap:
$55.57M
Revenue:
$2.72M
Net Income/Loss:
$-85.08M
P/E Ratio:
-0.4318
EPS:
-1.93
Net Cash Flow:
$-70.93M
1W Performance:
-16.66%
1M Performance:
-18.29%
6M Performance:
-37.81%
1Y Performance:
-77.48%
1-Day Range:
$0.83
$0.87
1-Week Range:
$0.7743
$1.02
52-Week Range:
$0.6922
$4.99
Shattuck Labs Inc Stock (STTK) Company Profile
Name
Shattuck Labs Inc
Sector
Industry
Phone
512-900-4690
Address
500 W. 5TH STREET, AUSTIN
Compare STTK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STTK
Shattuck Labs Inc
|
0.8334 | 55.57M | 2.72M | -85.08M | -70.93M | -1.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.62 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.36 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
331.91 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
543.48 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.49 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Shattuck Labs Inc Stock (STTK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-25 | Initiated | Leerink Partners | Outperform |
| Oct-02-24 | Downgrade | Citigroup | Buy → Neutral |
| Oct-02-24 | Downgrade | Needham | Buy → Hold |
| Oct-01-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jun-17-24 | Downgrade | BTIG Research | Buy → Neutral |
| Aug-31-22 | Initiated | BTIG Research | Buy |
| Jun-01-22 | Initiated | Citigroup | Buy |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-14-21 | Initiated | Berenberg | Buy |
| Jan-11-21 | Initiated | Evercore ISI | Outperform |
| Nov-03-20 | Initiated | Citigroup | Buy |
| Nov-03-20 | Initiated | Cowen | Outperform |
| Nov-03-20 | Initiated | Needham | Buy |
View All
Shattuck Labs Inc Stock (STTK) Latest News
Bank of America Corp DE Raises Stock Position in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Here's Why We're Watching Shattuck Labs' (NASDAQ:STTK) Cash Burn Situation - Yahoo Finance
Millennium Management LLC Sells 34,034 Shares of Braemar Hotels & Resorts (NYSE:BHR) - Defense World
Two Sigma Investments LP Takes $206,000 Position in Avino Silver & Gold Mines Ltd. (NYSE:ASM) - Defense World
Two Sigma Investments LP Sells 59,670 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Millennium Management LLC Cuts Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Millennium Management LLC Makes New $220,000 Investment in ArrowMark Financial Corp. (NASDAQ:BANX) - Defense World
Two Sigma Advisers LP Sells 58,800 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Squarepoint Ops LLC Sells 61,563 Shares of Endeavor Group Holdings, Inc. (NYSE:EDR) - Defense World
Biotricity (NASDAQ:BTCY) Shares Down 10.5% – Here’s Why - Defense World
Mitchells & Butlers (LON:MAB) Stock Price Passes Above Two Hundred Day Moving Average – What’s Next? - Defense World
Bank of America Corp DE Boosts Position in iShares Asia 50 ETF (NASDAQ:AIA) - Defense World
Shattuck Labs, Inc. (NASDAQ:STTK) Shares Purchased by Deutsche Bank AG - Defense World
Admiral Group (LON:ADM) Stock Crosses Above 200 Day Moving Average – Here’s Why - Defense World
Universe Pharmaceuticals INC (NASDAQ:UPC) Short Interest Update - Defense World
Costain Group (LON:COST) Stock Price Passes Above Two Hundred Day Moving Average – Should You Sell? - Defense World
Fertilizer Stocks To Watch Now – June 1st - Defense World
Promising Healthcare Stocks To Watch Now – June 1st - Defense World
Outdoor Stocks To Research – June 1st - Defense World
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $7.50 Consensus Target Price from Analysts - Defense World
General Mills (NYSE:GIS) Stock Acquired Rep. Robert Bresnahan, Jr. - Defense World
The Gross Law Firm Announces Class Actions on Behalf of Shareholders of STTK, ASTR and FB - ACCESS Newswire
Shattuck Labs, Inc. (NASDAQ:STTK) Stock Holdings Increased by Northern Trust Corp - Defense World
Invinity Energy Systems’ (IES) Buy Rating Reaffirmed at Canaccord Genuity Group - Defense World
Genocea Biosciences (NASDAQ:GNCAQ) vs. Coherus BioSciences (NASDAQ:CHRS) Critical Survey - Defense World
Adagene Inc. (NASDAQ:ADAG) Sees Significant Growth in Short Interest - Defense World
AMETEK, Inc. (NYSE:AME) Receives Consensus Rating of “Moderate Buy” from Analysts - Defense World
a2 Milk (OTCMKTS:ACOPF) Stock Price Down 16.3% – Time to Sell? - Defense World
D-BOX Technologies (TSE:DBO) Stock Price Up 2.6% – Should You Buy? - Defense World
Peritoneal Cancer Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - The Globe and Mail
Dimensional Fund Advisors LP Sells 109,300 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Is Enbridge Stock Still Worth Owning After Strong Q1 Earnings? - The Globe and Mail
Shattuck Labs, Inc. (NASDAQ:STTK) Receives $7.50 Average PT from Brokerages - Defense World
LAWSUITS FILED AGAINST STTK, ASTR and CELHJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Lawsuits Filed Against STTK, EDU and ASTR – Jakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
LAWSUITS FILED AGAINST BMBL, STTK and SPWRJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
LAWSUITS FILED AGAINST STTK, RIVN and AIJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Renaissance Technologies LLC Reduces Stock Holdings in Shattuck Labs, Inc. (NASDAQ:STTK) - Defense World
Renaissance Technologies LLC Sells 222,500 Shares of Shattuck Labs, Inc. (NASDAQ:STTK) - The AM Reporter
5 No-Brainer AI Stocks to Buy in May - The Globe and Mail
Shattuck Labs Advances SL-325 Program Amid Financial Progress - TipRanks
LAWSUITS FILED AGAINST FSLR, CLVT and STTKJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Shattuck Labs, Inc. (NASDAQ:STTK) Shares Bought by JPMorgan Chase & Co. - Defense World
Shattuck Labs First Quarter 2025 Earnings: US$0.27 loss per share (vs US$0.37 loss in 1Q 2024) - Yahoo Finance
STTK Prepares for Phase 1 Clinical Trial of SL-325 | STTK Stock News - GuruFocus
Qualigen Therapeutics, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K - The Manila Times
Shattuck Labs Inc (STTK) Reports Q1 2025 EPS of -$0.27, Narrowly Beating Estimates - GuruFocus
Shattuck Labs Reports First Quarter 2025 Financial Results and R - GuruFocus
Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights - The Manila Times
Shattuck Labs, Inc. SEC 10-Q Report - TradingView
Shattuck Labs Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Shattuck Labs Inc Stock (STTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Shattuck Labs Inc Stock (STTK) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Redmile Group, LLC | Director |
Dec 04 '24 |
Sale |
1.25 |
133,371 |
166,714 |
5,406,353 |
0.68%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):